Moleculin Biotech, Inc., (NASDAQ: MBRX) today announced that it has entered into definitive agreements with institutional investors to purchase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE